Bioorthogonal imaging tracks lipid metabolism in tumor spheroids, revealing insights into chemoresistance.
Altered lipid metabolism has emerged as a critical hallmark of chemoresistance. However, interrogating the dynamic metabolic responses within biologically relevant three-dimensional (3D) tumor models remains challenging. Here, we present a bioorthogonal stimulated Raman scattering (SRS) imaging strategy to in situ, real-time track the spatiotemporal dynamics of fatty acid metabolism in live patient-derived 3D tumor spheroids. By simultaneously detecting carbon-deuterium (C-D) vibrational signals from incorporated exogenous fatty acids and intrinsic CH2 signals from pre-existing lipids, we performed longitudinal tracking of metabolic flux and quantified the subcellular lipid distribution in cisplatin-sensitive and -resistant ovarian cancer spheroids. Our results revealed substantial spatiotemporal heterogeneity in fatty acid incorporation, including preferential peripheral enrichment and dynamic edge-to-core gradients within tumor spheroid. Notably, cisplatin-resistant spheroids exhibited increased fatty acid uptake and preferential storage within lipid droplets (LDs), indicating a distinct lipid handling strategy associated with chemoresistance. Overall, our study showcases bioorthogonal SRS imaging as a powerful approach for resolving metabolic heterogeneity in live 3D tumor models and provides new insights into the lipid metabolic adaptations associated with chemoresistance.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: